The 2024 Copay Congress highlighted a healthcare landscape in rapid transformation, driven by shifts in patient affordability programs, regulatory changes, and evolving patient needs.
Key trends included:
- Navigating Copay Trends (Amgen): "Buy-and-bill programs now account for approximately half of all specialty product copay assistance". Learn how evolving program models, such as matrix programs, are enhancing access for patients.
- Key Regulatory Impacts (Avalere Health): "PBM reforms and accumulator bans will shape how patients access medications in 2025". Discover how recent legislative changes could redefine patient affordability programs.
- The Inflation Reduction Act’s Influence (PhRMA): "With biologics given 13 years and small molecules only 9 years before price negotiations, we’re already seeing shifts in drug development priorities". Explore what these dynamics mean for innovation and strategy in the coming years.
Get the guide and learn why the path forward will require continued innovation and adaptation in 2025.